Abstract
The purpose of this study was to investigate the effects of celecoxib and ibuprofen on the proliferation, viability, and migration of MC3T3-E1 cells cultured on titanium surfaces. MC3T3-E1 cells were cultured on sandblasted titanium disks and allocated to one of the following interventional groups: (a) control (untreated group); (b) celecoxib (5 μM and 10 μM); (c) ibuprofen (5 μM and 10 μM); and (d) prostaglandin E2 (10 μM). Proliferation of attached cells was assessed over 9 days using an AlamarBlue assay. A trypan blue exclusion test was conducted to assess cell viability, where the relative percentages of live and dead cells were quantified using a hemocytometer over 2 days. A Boyden-Chamber Assay was utilized to assess cell migration over 33 days. The proliferation of cells treated with any intervention was not significantly different than that of the untreated group throughout the treatment period. However, celecoxib and ibuprofen significantly decreased the percentage of viable cells in a dose-dependent manner. Specifically, celecoxib (10 μM) and ibuprofen (5 μM and 10 μM) on day 1, and celecoxib (10 μM) on day 2 showed significantly higher percentages of dead cells compared to the untreated cells. There was a significant increase in migration of cells treated with ibuprofen (5 μM) compared with untreated cells on day 1; however, the migration of cells treated with any of the interventions was not significantly different from that of untreated cells on day 3. Cocnclusion: Nonsteroidal anti-inflammatory drugs at therapeutic doses did not significantly affect osteoblast proliferation and migration. However, higher dosages of celecoxib (10 μM) significantly reduced the cell viability and, therefore, can potentially affect the process of osseointegration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: The International journal of oral & maxillofacial implants
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.